Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GRAZAX in Allergic Rhinoconjunctivitis (GT-20)
NCT02437786Phase 4Completed
- Sponsor
- ALK-Abelló
- Start
- Sep 2009
- Primary completion
- Dec 2014
- Modality
- Biologic
- Countries
- 1
01
Overview
A Phase 4 trial of grass-pollen extract in allergic rhinoconjunctivitis (ARC), sponsored by ALK-Abelló. Started Sep 2009; status: completed.
02
Drugs
grass-pollen extract
03
Conditions
allergic rhinoconjunctivitis (ARC)
Beyond the preview
Go deeper on NCT02437786.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02437786.